Yea was pretty much a copy and paste from the last presentation, didn't stop me from giving it a good read again though.
Has me very excited for this year.
Rett has a good chance at Break Through designation due to the complete lack of available treatments, but I guess people could say that about a lot of drugs and the disorders they are meant to help. Only the best and most needed will make the cut.
Hold tight all, 60 days for the FDA to respond to Neuren, so the clock is already ticking and would explain the increase in buying.
Cheers,
Tim
NEU Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)